AP2167A - Multivalent avian influenza vaccines. - Google Patents

Multivalent avian influenza vaccines.

Info

Publication number: AP2167A
Authority: AP; ARIPO
Prior art keywords: avian influenza; influenza vaccines; multivalent; multivalent avian; vaccines
Prior art date: 2004-10-07

Application number

AP2007003955A

Other languages

English (en)

Other versions

AP2007003955A0 (en

Inventor

Juan Plana-Duran

Rut Vila-Quintana

Jordi Tarres-Call

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-07

Filing date

2005-10-06

Publication date

2010-11-12

2005-10-06 Application filed by Wyeth Corp filed Critical Wyeth Corp

2007-07-30 Publication of AP2007003955A0 publication Critical patent/AP2007003955A0/xx

2010-11-12 Application granted granted Critical

2010-11-12 Publication of AP2167A publication Critical patent/AP2167A/xx

Links

208000002979 Influenza in Birds Diseases 0.000 title 1
206010064097 avian influenza Diseases 0.000 title 1
229960003971 influenza vaccine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pulmonology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicinal Preparation (AREA)

AP2007003955A 2004-10-07 2005-10-06 Multivalent avian influenza vaccines. AP2167A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US61670704P	2004-10-07	2004-10-07
US64845905P	2005-01-31	2005-01-31
PCT/US2005/035925 WO2006041978A2 (en)	2004-10-07	2005-10-06	Multivalent avian influenza vaccines

Publications (2)

Publication Number	Publication Date
AP2007003955A0 AP2007003955A0 (en)	2007-07-30
AP2167A true AP2167A (en)	2010-11-12

Family

ID=36148890

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AP2007003955A AP2167A (en)	2004-10-07	2005-10-06	Multivalent avian influenza vaccines.

Country Status (17)

Country	Link
US (1)	US8067013B2 (xx)
EP (1)	EP1796720B1 (xx)
JP (1)	JP5105524B2 (xx)
KR (1)	KR101370464B1 (xx)
CN (1)	CN101035559B (xx)
AP (1)	AP2167A (xx)
AR (1)	AR051636A1 (xx)
AU (1)	AU2005294322A1 (xx)
BR (1)	BRPI0516542B1 (xx)
CA (1)	CA2581355C (xx)
ES (1)	ES2467094T3 (xx)
MX (1)	MX2007004004A (xx)
MY (1)	MY153290A (xx)
NZ (1)	NZ553975A (xx)
TW (1)	TWI365074B (xx)
WO (1)	WO2006041978A2 (xx)
ZA (1)	ZA200702876B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2007053899A1 (en) *	2005-11-10	2007-05-18	Diva Solutions Pty Ltd	Differentiating therapeutic composition
US9072701B2 (en) *	2006-04-21	2015-07-07	St. Jude Children's Research Hospital	Avian influenza viruses, vaccines, compositions, formulations, and methods
WO2008048984A2 (en) *	2006-10-18	2008-04-24	St. Jude Children's Research Hospital	Methods and compositions for preparing a universal influenza vaccine
CL2008000747A1 (es) *	2007-03-16	2008-04-25	Wyeth Corp	Composicion de vacuna que comprende una primera y una segunda cepa inactivada del virus de la influenza aviar; metodo para vacunar un ave.
GB0810305D0 (en) *	2008-06-05	2008-07-09	Novartis Ag	Influenza vaccination
RU2358760C1 (ru) *	2008-03-17	2009-06-20	Открытое Акционерное Общество "Институт Биотехнологий Ветеринарной Медицины"	Способ изготовления инактивированной эмульгированной вакцины против гриппа птиц и вакцина инактивированная эмульгированная против гриппа птиц
EP2310045A1 (en)	2008-06-25	2011-04-20	Novartis AG	Rapid responses to delayed booster immunisations
WO2010041702A1 (ja)	2008-10-08	2010-04-15	株式会社ポッカコーポレーション	抗鳥インフルエンザウイルス剤及び抗鳥インフルエンザウイルス剤含有製品
CN107949636B (zh) *	2015-06-04	2021-11-09	香港大学	活减毒病毒以及生产和使用方法
KR101964044B1 (ko)	2018-03-14	2019-04-02	인제대학교 산학협력단	재조합 아데노바이러스를 이용한 다가형 인플루엔자 생백신 플랫폼

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0399843A2 (en) *	1989-05-25	1990-11-28	Chiron Corporation	Adjuvant formulation comprising a submicron oil droplet emulsion
WO2003086453A1 (en) *	2002-04-12	2003-10-23	Ilaria Capua	Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6159472A (en) *	1998-11-16	2000-12-12	Akzo Nobel N.V.	Intradermal Avian immunization with inactivated vaccines

2005
- 2005-09-29 TW TW094133947A patent/TWI365074B/zh not_active IP Right Cessation
- 2005-10-06 ES ES05816010.2T patent/ES2467094T3/es not_active Expired - Lifetime
- 2005-10-06 US US11/244,574 patent/US8067013B2/en active Active
- 2005-10-06 AR ARP050104219A patent/AR051636A1/es unknown
- 2005-10-06 NZ NZ553975A patent/NZ553975A/en not_active IP Right Cessation
- 2005-10-06 AP AP2007003955A patent/AP2167A/xx active
- 2005-10-06 CN CN2005800336971A patent/CN101035559B/zh not_active Expired - Fee Related
- 2005-10-06 KR KR1020077009400A patent/KR101370464B1/ko not_active Expired - Fee Related
- 2005-10-06 MY MYPI20054709A patent/MY153290A/en unknown
- 2005-10-06 JP JP2007535798A patent/JP5105524B2/ja not_active Expired - Fee Related
- 2005-10-06 CA CA2581355A patent/CA2581355C/en not_active Expired - Lifetime
- 2005-10-06 WO PCT/US2005/035925 patent/WO2006041978A2/en not_active Ceased
- 2005-10-06 EP EP05816010.2A patent/EP1796720B1/en not_active Expired - Lifetime
- 2005-10-06 MX MX2007004004A patent/MX2007004004A/es active IP Right Grant
- 2005-10-06 AU AU2005294322A patent/AU2005294322A1/en not_active Abandoned
- 2005-10-06 BR BRPI0516542A patent/BRPI0516542B1/pt not_active IP Right Cessation
2007
- 2007-04-05 ZA ZA200702876A patent/ZA200702876B/xx unknown

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0399843A2 (en) *	1989-05-25	1990-11-28	Chiron Corporation	Adjuvant formulation comprising a submicron oil droplet emulsion
WO2003086453A1 (en) *	2002-04-12	2003-10-23	Ilaria Capua	Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FATUNMBI O.O. ET AL. *
LU XIUHUA ET AL. *

Also Published As

Publication number	Publication date
AP2007003955A0 (en)	2007-07-30
CA2581355C (en)	2016-01-26
BRPI0516542A (pt)	2008-09-09
WO2006041978A3 (en)	2006-08-03
TWI365074B (en)	2012-06-01
JP2008515906A (ja)	2008-05-15
US8067013B2 (en)	2011-11-29
CN101035559B (zh)	2011-08-17
NZ553975A (en)	2010-04-30
MX2007004004A (es)	2007-05-10
CN101035559A (zh)	2007-09-12
EP1796720A2 (en)	2007-06-20
ES2467094T3 (es)	2014-06-11
CA2581355A1 (en)	2006-04-20
AR051636A1 (es)	2007-01-31
AU2005294322A1 (en)	2006-04-20
TW200617166A (en)	2006-06-01
WO2006041978A2 (en)	2006-04-20
JP5105524B2 (ja)	2012-12-26
MY153290A (en)	2015-01-29
ZA200702876B (en)	2008-09-25
KR101370464B1 (ko)	2014-03-06
EP1796720B1 (en)	2014-04-23
US20060204976A1 (en)	2006-09-14
KR20070059180A (ko)	2007-06-11
BRPI0516542B1 (pt)	2015-11-17

Publication	Publication Date	Title
SI2091560T1 (sl)	2014-05-30	Cepiva proti ptičji gripi za mačke
TWI365191B (en)	2012-06-01	Vaccine
IL178890A0 (en)	2007-03-08	Vaccines
ZA200702876B (en)	2008-09-25	Multivalent avian influenza vaccines
GB0922611D0 (en)	2010-02-10	Improved vaccines
NO20054608D0 (no)	2005-10-06	Influensavirusvaksine
IL196024A0 (en)	2011-08-01	Influenza vaccine
MA28885B1 (fr)	2007-09-03	vaccins
GB0513421D0 (en)	2005-08-03	Vaccines
MA28639B1 (fr)	2007-06-01	Vaccins
PL2422810T3 (pl)	2015-03-31	Szczepionka przeciw grypie
PT1942933E (pt)	2013-01-24	Vacinas contra a gripe canina
SI1751276T1 (sl)	2009-06-30	Cepivo, ki obsega oslabljen pestivirus
GB0411150D0 (en)	2004-06-23	Vaccine
EP1807116A4 (en)	2007-10-31	FLU VACCINATION
GB0524409D0 (en)	2006-01-11	Vaccines
GB0413510D0 (en)	2004-07-21	Vaccine
GB2460969B (en)	2010-02-17	Vaccines for intranasal administration
BRPI0919168A2 (pt)	2015-12-08	pestivírus mutante, e, vacina.
ES2365717T5 (es)	2011-10-10	Vacunacion meningococica conjugada.
GB0428381D0 (en)	2005-02-02	Vaccine
GB0419918D0 (en)	2004-10-13	Vaccine
GB0406598D0 (en)	2004-04-28	Vaccine
AP2709A (en)	2013-07-30	An anti-theileriosis vaccine
HK1102763A (en)	2007-12-07	Vaccines for the rapid response to pandemic avian influenza